Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 2 de 2
Filtre
Ajouter des filtres








Gamme d'année
1.
Acta Physiologica Sinica ; (6): 475-484, 2008.
Article Dans Chinois | WPRIM | ID: wpr-316702

Résumé

This work was performed to determine the role of delta-opioid receptor (DOR) in protection against acute ischemia/reperfusion injury. Transient (1 h) focal cerebral ischemia was induced by middle cerebral artery occlusion (MCAO). DOR agonist TAN-67 (30 nmol, 60 nmol, 200 nmol), DOR antagonist naltrindole (20 nmol, 50 nmol, 100 nmol) or artificial cerebral spinal fluid (aCSF) was injected respectively into the lateral cerebroventricle of the rat 30 min before the induction of brain ischemia. Neurological deficits were assessed by the five-grade system (Longa's methods). The brain infarct was measured by cresyl violet (CV) staining and infarct volume was analyzed by an image processing and analysis system. The expression of DOR was detected by Western blot. The results showed that 60 nmol TAN-67 significantly reduced the infarct volume (P<0.05), attenuated neurological deficits (P<0.05) and tended to increase the expression of about 60 kDa DOR protein (P>0.05), while 100 nmol naltrindole aggravated ischemic damage and decreased about 60 kDa DOR protein expression (P<0.05). These results suggest that DOR activation protects the brain against acute ischemia/reperfusion injury in rat.


Sujets)
Animaux , Rats , Encéphale , Anatomopathologie , Encéphalopathie ischémique , Traitement médicamenteux , Infarctus du territoire de l'artère cérébrale moyenne , Injections ventriculaires , Naltrexone , Pharmacologie , Quinoléines , Pharmacologie , Rat Sprague-Dawley , Récepteur delta , Lésion d'ischémie-reperfusion
2.
Acta Physiologica Sinica ; (6): 325-328, 2002.
Article Dans Anglais | WPRIM | ID: wpr-318992

Résumé

The present study was to investigate the effects of intracerebroventricular (i.c.v.) injection of interleukin-1beta (IL-1beta) on thermal nociception in SD rats. The rats were divided into control and drug-administration groups. The animals of control group were given vehicle solution via i.c.v. injection. The animals of drug-administered groups were given IL-1beta at different doses (5, 50 and 500 pg/kg b.w.) via i.c.v. injection. IL-1 receptor antagonist (IL-1ra, 50 ng/kg) was injected 20 min before injection of IL-1beta or vehicle solution. The nociceptive threshold, which was represented as paw withdrawal latency (PWL), to a noxious thermal stimulation was measured using an analgesiameter. I.c.v. injection of IL-1beta dose-dependently shortened the PWL. At the dose of 500 pg/kg, the shortening of the PWL occurred at 20 min, reaching a peak within 40 min, lasted 100 min after injection, then gradually returned to the baseline level. Pretreatment with IL-1ra completely blocked the effects of IL-1beta-induced shortening in PWL. The results obtained suggest that IL-1beta may induce hyperalgesia in rats through binding to IL-1 receptors in the brain.


Sujets)
Animaux , Rats , Température élevée , Hyperalgésie , Traitement médicamenteux , Injections ventriculaires , Antagoniste du récepteur à l'interleukine-1 , Pharmacologie , Interleukine-1 bêta , Pharmacologie , Nociception , Rat Sprague-Dawley , Récepteurs à l'interleukine-1 , Métabolisme , Toucher
SÉLECTION CITATIONS
Détails de la recherche